Eosinophilic granuloma of the skin: response to intralesional corticosteroid injection.
Langerhans cell histiocytosis (LCH) is a histiocytic disorder in which the Langerhans cell is arrested in a premature, partially active state. The disease comprises a spectrum of disorders, the most benign of which is a single-system unifocal disease. Lesions in single-system LCH are typically limited to the bone. We report a case of a 66-year-old man with a single-system disease limited to the skin, who was successfully treated with intralesional triamcinolone. This minimally invasive treatment method warrants further studies of intralesional corticosteroid injection for skin lesions of LCH.
Myers
Elizabeth
E
Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Shea
Christopher R
CR
Krausz
Thomas
T
Petronic-Rosic
Vesna
V
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004803:Eosinophilic Granuloma / Q000188:drug therapy* / Q000473:pathology; D004890:Erythema / Q000473:pathology; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007267:Injections; D008297:Male; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D014221:Triamcinolone / Q000008:administration & dosage / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D014221:Triamcinolone